{
    "nct_id": "NCT05391126",
    "official_title": "GENOCARE: a Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care",
    "inclusion_criteria": "* Patients must have histologically confirmed stage I-IV pancreas or stage III-IV colorectal cancer who are planning to undergo treatment.\n* Prior treatment is allowed, specifically surgery and/or radiation and non-irinotecan containing regimens are allowed.\n* Age ≥ 18 years.\n* ECOG performance status ≤ 1.\n* Patients must have adequate organ and marrow function as defined below:\n* Measurable or non-measurable disease.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Patients who received prior treatment with irinotecan are excluded.\n* Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with targeted therapy, in the opinion of the treating physician.\n* Pregnant women are excluded from this study.\n* Patients who are not planned for treatment of their cancer.",
    "miscellaneous_criteria": ""
}